Haemorrhagic cystitis following the administration of voriconazole in the treatment of central nervous system aspergillosis: a case report

Haemorrhagic cystitis following the administration of voriconazole in the treatment of central nervous system aspergillosis: a case report

Central nervous system aspergillosis (CNS-A) is a rare and fatal fungal infection. Voriconazole is the recommended treatment for CNS-A. The therapeutic effect of voriconazole is good, but its use is limited due to adverse reactions. This case report describes a 37-year-old male patient that had prev...

Full description

Bibliographic Details
Main Authors:	Zhaohao Zeng, Hong Luo, Kunyu Huang, Lianfang Xue, Hui Liu, Xiaoting Li, Lu Wang, Haimei Cen, Wei Bi, Yu Zhang
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-12-01
Series:	Journal of International Medical Research
Online Access:	https://doi.org/10.1177/0300060520974924

Similar Items

Orbital Aspergillosis: Voriconazole – The New Standard Treatment
by: Derek H. Ohlstein, et al.
Published: (2012-02-01)

Role of Voriconazole in the Management of Invasive Central Nervous System Aspergillosis: A Case Series from a Tertiary Care Centre in India
by: Nitin Gupta, et al.
Published: (2020-08-01)

Central Nervous System Aspergillosis: An Unexpected Complication following Neurosurgery
by: Jose Armando Gonzales Zamora, et al.
Published: (2018-05-01)

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
by: Sacha Sarfati, et al.
Published: (2022-07-01)

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
by: Karthaus M
Published: (2011-04-01)

The first study of plasma voriconazole concentration in Thai patient with invasive aspergillosis
by: M. Chayakulkeeree, et al.
Published: (2014-04-01)

The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib
by: Rémy Nyga, et al.
Published: (2019-03-01)

Pharmacology and metabolism of voriconazole and posaconazole in the treatment of invasive aspergillosis-review of the literature
by: Sandherr M, et al.
Published: (2011-04-01)

Modeling and Simulation as a Tool to Assess Voriconazole Exposure in the Central Nervous System
by: Keli Jaqueline Staudt, et al.
Published: (2023-06-01)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
by: Grau S, et al.
Published: (2016-12-01)

Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report
by: Gu L, et al.
Published: (2023-08-01)

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01)

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01)

Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies
by: Kem P Krueger, et al.
Published: (2009-08-01)

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis
by: Ferguson MJ, et al.
Published: (2017-09-01)

Cytomegalovirus haemorrhagic cystitis in a pregnant patient with AIDS
by: Bernard Marais, et al.
Published: (2023-03-01)

Haemorrhagic cystitis due to cytomegalovirus in a patient with AIDS
by: Winston P. R. Padayachee, et al.
Published: (2020-07-01)

Central Nervous System Aspergillosis causing Spinal Cord Compression
by: Faraz Ahmed, et al.
Published: (2010-07-01)

Poststernotomy aspergillosis: successful treatment with voriconazole, surgical debridement and vacuum-assisted closure therapy
by: Rinaldo Focaccia Siciliano, et al.
Published: (2012-01-01)

Haemorrhagic cystitis and renal dysfunction associated with high dose benzylpenicillin.
by: Adlam, D, et al.
Published: (2000)

Resolution of orbitocerebral aspergillosis during combination treatment with voriconazole and amphotericin plus adjunctive cytokine therapy.
by: Bethell, D, et al.
Published: (2004)

Relationship between voriconazole trough concentration and liver injury in elderly patients with lung invasive aspergillosis
by: CHENG Lin, et al.
Published: (2020-10-01)

Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis
by: Brendan Le Daré, et al.
Published: (2021-04-01)

Central Nervous System Toxicity of Voriconazole: Risk Factors and Threshold – A Retrospective Cohort Study
by: Yang L, et al.
Published: (2022-12-01)

Successful treatment of multiple intracerebral aspergillosis with voriconazole alone in an Egyptian diabetic patient with autoimmune hemolytic anemia
by: Hamdy Ibrahim, et al.
Published: (2023-10-01)

Invasive aspergillosis: Is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?
by: G Schnetzler, et al.
Published: (2006-10-01)

Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
by: Ronald Olum, et al.
Published: (2020-01-01)

Uncommon Haemorrhagic Cystitis of Infectious Origin: A Narrative Review for Urologists
by: Ambrosini F, et al.
Published: (2023-08-01)

Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis
by: Athanasios Dellis, et al.

Pulmonary and central nervous system aspergillosis in a patient with COVID-19 infection
by: Ljubičić Jelena, et al.
Published: (2022-01-01)

Tumoral form of aspergillosis in central nervous system (cerebral aspergilloma): case report
by: Eberval Gadelha Figueiredo, et al.

Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
by: Milo Gatti, et al.
Published: (2023-04-01)

Clinical Analysis of Intravenous and Oral Sequential Treatment With Voriconazole for Candida Central Nervous System Infection in Six Premature Infants
by: Yingying Zhu, et al.
Published: (2021-06-01)

Efficacy and safety of voriconazole in the treatment of invasive pulmonary aspergillosis in patients with liver failure: study protocol for a randomized controlled clinical trial
by: Xue Yu, et al.
Published: (2023-12-01)

Paradoxical Response after a Voriconazole Treatment in an Immunocompetent Host with a Skull Base Osteomyelitis due to Invasive Aspergillosis
by: Jeong-Min Kim, et al.
Published: (2017-12-01)

Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
by: Louis Yi Ann Chai, et al.
Published: (2014-01-01)

Central nervous system aspergillosis misdiagnosed as Toxoplasma gondii encephalitis in a patient with AIDS: a case report
by: Hong-Hong Yang, et al.
Published: (2022-09-01)

Treatment of Resıstant Cyclophosphamide Induced Haemorrhagic Cystıtıs: Revıew of Literature and Three Case Reports
by: Turgay Ebiloglu, et al.
Published: (2016-04-01)

Management of BK virus-associated haemorrhagic cystitis in allogeneic stem cell transplant recipients
by: Aditya Jandial, et al.
Published: (2021-02-01)

Real World Experience using Cidofovir in BK Polyomavirus Haemorrhagic Cystitis following Stem Cell Transplantation-Are Generics Equally Efficacious?
by: Sharon Lionel, et al.
Published: (2022-08-01)